Investor Alert

New York Markets Open in:

March 30, 2020, 5:47 p.m. EDT

Stock investors are too optimistic — they’re running up Abbott, Johnson & Johnson and General Motors without doing any research

Companies that are pitching in to help defeat the deadly virus may get kudos, but they won’t earn any extra money

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    SPDR Dow Jones Industrial Average ETF Trust (DIA)
  • X
    Dow Jones Industrial Average (DJIA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Nigam Arora


20th Century Fox Home Entertainment. All rights reserved./Courtesy Everett Collection

We all want the coronavirus to die off. It is the government’s job to spin reality to keep up the country’s morale. It is the prudent investor’s job to discern the truth.

The key questions for investors are: Where is the bottom in the stock market? Should you buy or sell stocks now?

Let’s examine with the help of a chart.

Please click here for a chart of the Dow Jones Industrial Average ETF /zigman2/quotes/208954582/composite DIA +1.34% , which tracks the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.39% .

Note the following:

• Look at the last bar. After touching the top band of the mother of support zones, the stock market has moved above the top band of the support/resistance zone. From a technical perspective, this shows significant optimism in the face of worsening coronavirus news.

• The chart shows that RSI (relative strength index) is nowhere near the level shown at the last major bottom. This indicates there is significant risk in this market that investors are underappreciating.

• The chart shows the Arora call on Jan. 22 that the coronavirus could cause problems for the stock market. This call was repeated on Jan. 30. Meanwhile, the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.64% was on its way to new high Feb. 19.

• When the Dow was in 16,000-point range, I was calling for the index to reach 30,000 while President Trump was in office.

• When the Dow reached almost 30,000, I didn’t raised my target. It was not because I knew the coronavirus would come along, but because our adaptive ZYX Asset Allocation Model was keeping us cautious.

Ask Arora: Nigam Arora answers your questions about investing in stocks, ETFs, bonds, gold and silver, oil and currencies. Have a question? Send it to Nigam Arora.

Where’s the bottom?

The mother of support zones has an 80% probability of holding — this along with RSI should be the main reference points to look for a bottom. There is simply too much optimism in the stock market, and in many cases investors are buying without doing research.

Here are a few examples:

• Abbott Laboratories /zigman2/quotes/203724446/composite ABT +2.21% has come up with a coronavirus test that takes five minutes. The revenues from the coronavirus test will dwarf those that Abbott is likely to lose due to issues related to coronavirus. Investors are running up the stock.

• Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.80% is making great progress on a coronavirus vaccine. Johnson & Johnson is likely to sell the vaccine at cost. This will have no material increase in earnings. Investors are running up the stock.

• General Motors /zigman2/quotes/205226835/composite GM +2.05% will make ventilators. It is selling them at cost, so they will have no impact on earnings. Investors are running up the stock.

• Medtronic /zigman2/quotes/206816578/composite MDT +0.76% makes ventilators, which are a small portion of its business. At the same time, Medtronic is suffering because its sales are likely to drop due to the postponement of non-essential surgeries. Investors aren’t seeing the whole picture. And, yes, they are running up the stock.

The foregoing shows that there is simply too much optimism. Investors aren’t able to judge correctly. In my 30-plus years in the stock market, I have never seen investors behave this way. To decide on buying or selling, use an objective framework. Please read “Stock market investors are asking ‘should I buy or sell?’ Here’s how to decide.”

Answers to your questions

Answers to some of your questions are in my previous writings. You can access them here.

Disclosure: Subscribers to The Arora Report may have positions in the securities mentioned in this article or may take positions at any time. <INTERNAL-PAGE URL="/author/nigam-arora">Nigam Arora</INTERNAL-PAGE> is an investor, engineer and nuclear physicist by background. He is the founder of The Arora Report, which publishes four newsletters. Nigam can be reached at Nigam@TheAroraReport.com.

/zigman2/quotes/208954582/composite
US : U.S.: NYSE Arca
$ 272.00
+3.59 +1.34%
Volume: 2.13M
Aug. 5, 2020 4:00p
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
27,201.52
+373.05 +1.39%
Volume: 369.98M
Aug. 5, 2020 5:27p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,327.77
+21.26 +0.64%
Volume: 2.45B
Aug. 5, 2020 5:27p
loading...
/zigman2/quotes/203724446/composite
US : U.S.: NYSE
$ 102.14
+2.21 +2.21%
Volume: 4.42M
Aug. 5, 2020 4:02p
P/E Ratio
58.87
Dividend Yield
1.41%
Market Cap
$176.93 billion
Rev. per Employee
$296,874
loading...
/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 148.40
+1.18 +0.80%
Volume: 5.49M
Aug. 5, 2020 4:00p
P/E Ratio
26.08
Dividend Yield
2.72%
Market Cap
$387.60 billion
Rev. per Employee
$603,509
loading...
/zigman2/quotes/205226835/composite
US : U.S.: NYSE
$ 26.33
+0.53 +2.05%
Volume: 9.25M
Aug. 5, 2020 4:00p
P/E Ratio
25.07
Dividend Yield
0.00%
Market Cap
$36.92 billion
Rev. per Employee
$849,994
loading...
/zigman2/quotes/206816578/composite
US : U.S.: NYSE
$ 97.02
+0.73 +0.76%
Volume: 3.65M
Aug. 5, 2020 4:00p
P/E Ratio
27.38
Dividend Yield
2.39%
Market Cap
$129.15 billion
Rev. per Employee
$353,777
loading...

Nigam Arora is an engineer, nuclear physicist, author, and entrepreneur and the founder of two Inc. 500 fastest growing companies. He is also the developer of the ZYX Change Method to profit from change by investing. The premise is that most money is made by predicting change before the crowd. Arora is the chief investment officer at The Arora Report and the editor of four newsletters that track the ZYX Change Method. Nigam can be reached at Nigam@TheAroraReport.com

This Story has 0 Comments
Be the first to comment
More News In
Investing

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.